miR-133 inhibits proliferation and promotes apoptosis by targeting LASP1 in lupus nephritis
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 114, 104384
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- MicroRNAs Implicated in the Immunopathogenesis of Lupus NephritisJournal of Immunology Research, 2013
- Survival analysis and causes of mortality in patients with lupus nephritisNephrology Dialysis Transplantation, 2012
- The functional significance of miR-1 and miR-133a in renal cell carcinomaEuropean Journal of Cancer, 2012
- Mesangial Cell-Specific Antibodies Are Central to the Pathogenesis of Lupus NephritisJournal of Immunology Research, 2011
- Multiethnic lupus cohorts: What have they taught us?Reumatología Clínica, 2011
- Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cellsThe FASEB Journal, 2010
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritisProceedings of the National Academy of Sciences, 2010
- p21 and p27: roles in carcinogenesis and drug resistanceExpert Reviews in Molecular Medicine, 2008
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007
- Lasp‐1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domainsFEBS Letters, 1995